Results 31 to 40 of about 31,037 (228)
Cannabidiol (CBD) related posts.
, 2023 Cannabidiol (CBD) related posts.
Christine Mary Hallinan (12319089) +3 more
core +1 more source
CANNABIDIOL- PROVOKES OR TREATS ANXIETY DISORDERS?
European Psychiatry, 2023 Introduction After the introduction of proposal regarding cannabidiol for the treatment of some psychiatric disorders including anxiety, there is confusion if cannabidiol use is associated with the provocation of anxiety symptoms or it can be safely ...
H. Arshad +5 more
doaj +1 more source
Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders
Frontiers in Pharmacology, 2016 Anxiety and trauma-related disorders are psychiatric diseases with a lifetime prevalence of up to 25%. Phobias and post-traumatic stress disorder (PTSD) are characterized by abnormal and persistent memories of fear-related contexts and cues.
Regimantas Jurkus +5 more
doaj +1 more source
Regulation of Innate Lymphoid Cells in Acute Kidney Injury: Crosstalk between Cannabidiol and GILZ
Journal of Immunology Research, 2020 Innate lymphoid cells (ILCs) have emerged as largely tissue-resident archetypal cells of the immune system. We tested the hypotheses that renal ischemia-reperfusion injury (IRI) is a contributing factor to polarization of ILCs and that glucocorticoid ...
Babak Baban +5 more
doaj +1 more source
Cannabidiol concentrations in individual lymph nodes
, 2021 Cannabidiol concentrations in individual lymph ...
Jewell, Adelaide
core +1 more source
Cobalt‐Catalyzed C─N Bond Formation via Metal‐Hydride Hydrogen Atom Transfer (MHAT)
Angewandte Chemie, EarlyView.Cobalt‐catalyzed metal‐hydride hydrogen atom transfer (Co‐MHAT) converts simple alkenes into C─N bonds under mild, near‐neutral conditions. A shared Co─H‐initiated radical/organocobalt intermediate is channeled into radical trapping, radical‐polar crossover, or radical ligand transfer, unifying hydroamination, hydroazidation, hydroamidation, and remote
Arman Khosravi, Ming‐Yu Ngai
wiley +2 more sources
Pharmaceutics, 2023 Cannabidiol (CBD) has previously been shown to inhibit inflammatory cytokine production in both in vitro and in vivo studies of neurodegenerative diseases.
Ilya Eydelman +5 more
doaj +1 more source
Stereoselective Synthetic Strategies to (-)-Cannabidiol [PDF]
, 2022 (-)-Cannabidiol (CBD) is a non-psychoactive compound that has already found many medical applications, from the treatment of epilepsy to other neurological disorders.
Barbieri, J +7 more
core +1 more source
Pharmaceutics, 2023 There is potential for cannabidiol to act as an analgesic, anxiolytic and antipsychotic active ingredient; however, there is a need to find alternate administration routes to overcome its low oral bioavailability.
Zahra Khabir +5 more
doaj +1 more source
Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis
Scientific Reports, 2021 Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children.
Nir Treves +6 more
doaj +1 more source